Results 141 to 150 of about 8,094 (158)

Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays

Journal of Pharmaceutical Investigation, 2020
Xin Shen, Shirui Mao
exaly  

Chitosan as a novel nasal delivery system for vaccines

Advanced Drug Delivery Reviews, 2001
L Illum, M Hinchcliffe, S S Davis
exaly  

Nasal IL-5 levels determine the response to anti–IL-5 treatment in patients with nasal polyps

Journal of Allergy and Clinical Immunology, 2006
Philippe Gevaert, Heinz Stammberger, Gabriele Holtappels   +2 more
exaly  

Cyclodextrins in nasal drug delivery

Advanced Drug Delivery Reviews, 1999
F W H M Merkus, E Marttin, Paul-Hugo M van der Kuy   +2 more
exaly  

Staphylococcus aureus and the ecology of the nasal microbiome

Science Advances, 2015
Cindy M Liu, Lance B Price, Bruce A Hungate   +2 more
exaly  

Chitosan in nasal delivery systems for therapeutic drugs

Journal of Controlled Release, 2014
Luca Casettari, Lisbeth Illum
exaly  

An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy

American Journal of Respiratory and Critical Care Medicine, 2019
Oriol Roca, Berta Caralt, Jonathan Messika   +2 more
exaly  

Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice

Allergy: European Journal of Allergy and Clinical Immunology, 2016
Giancarlo Ottaviano
exaly  

In vitro cell models to study nasal mucosal permeability and metabolism

Advanced Drug Delivery Reviews, 1998
Hans P Merkle
exaly  

Efficacy and safety of mometasone furoate nasal spray in nasal polyposis

Journal of Allergy and Clinical Immunology, 2005
Eric Schenkel, M Danzig
exaly